Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
1.46 CNY
1.12 B CNY
5.63 B CNY
207.03 M
About SUNFLOWER PHARMACE
Sector
CEO
Yi Guan
Headquarters
Harbin
Website
Founded
2005
ISIN
CNE100001WT7
FIGI
BBG006FYHLF4
Sunflower Pharmaceutical Group Co., Ltd. engages in the research and development, manufacture, and marketing of chemical medicines and health products. Its business scopes include children medicine, adult medicine, generic medicine, and large health businesses. Its Children Medicine business offers pediatric chewable tablets, and granules. Its Adult Medicine business covers medicines for common cold, digestive system disease, rheumatism and bone disease, and heart disease. Its Generic Medicine business is involved in the marketing of over the counter medicines. Its Large Health business focuses on probiotics, children's mineral supplements, and medical devices. The company was founded by Yan Bin Guan on September 7, 2005 and is headquartered in Harbin, China.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 002737 is 20.80 CNY — it has decreased by −0.67% in the past 24 hours. Watch SUNFLOWER PHARMACE stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on SZSE exchange SUNFLOWER PHARMACE stocks are traded under the ticker 002737.
002737 stock has risen by 0.97% compared to the previous week, the month change is a 4.00% rise, over the last year SUNFLOWER PHARMACE has showed a −20.28% decrease.
002737 reached its all-time high on Jun 4, 2015 with the price of 38.13 CNY, and its all-time low was 10.96 CNY and was reached on Dec 30, 2014. View more price dynamics on 002737 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
002737 stock is 1.50% volatile and has beta coefficient of 1.33. Track SUNFLOWER PHARMACE stock price on the chart and check out the list of the most volatile stocks — is SUNFLOWER PHARMACE there?
Today SUNFLOWER PHARMACE has the market capitalization of 12.23 B, it has increased by 0.14% over the last week.
Yes, you can track SUNFLOWER PHARMACE financials in yearly and quarterly reports right on TradingView.
SUNFLOWER PHARMACE is going to release the next earnings report on Apr 25, 2025. Keep track of upcoming events with our Earnings Calendar.
002737 net income for the last quarter is 100.50 M CNY, while the quarter before that showed 231.15 M CNY of net income which accounts for −56.52% change. Track more SUNFLOWER PHARMACE financial stats to get the full picture.
Yes, 002737 dividends are paid annually. The last dividend per share was 1.50 CNY. As of today, Dividend Yield (TTM)% is 7.16%. Tracking SUNFLOWER PHARMACE dividends might help you take more informed decisions.
SUNFLOWER PHARMACE dividend yield was 5.77% in 2023, and payout ratio reached 78.28%. The year before the numbers were 4.31% and 67.34% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 25, 2024, the company has 5.78 K employees. See our rating of the largest employees — is SUNFLOWER PHARMACE on this list?
Like other stocks, 002737 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SUNFLOWER PHARMACE stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SUNFLOWER PHARMACE technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SUNFLOWER PHARMACE stock shows the sell signal. See more of SUNFLOWER PHARMACE technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.